optum rx glp-1 coverage launches solution for weight management | Optum posted on the topic Home | OptumRx
Description
PX Therapeutics
Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.
Specifically, the trial reported an average weight loss of 17.5% and 24.4% at 24 and 48 weeks, respectively
Korean Ginseng & Green Tea Leaf Extract Provide steady, all-day energy without the crash
Optimum cellular metabolism
